Khademhosseini, Ali PhD
Professor at
Harvard University (HU), Cambridge MA
Researcher
with 1057 publications
in the last 22 years
ORCID:
0000-0002-2692-1524
Ali Khademhosseini is currently a CEO of Terasaki Institute for Biomedical Innovation after leaving Amazon Web Services (AWS) Inc. May. 2020. In addition, he is the Founding Director of the Center for Minimally Invasive Therapeutics. He is a former Professor of Bioengineering, Chemical Engineering and Radiology at the University of California-Los Angeles (UCLA). He joined UCLA as the Levi Knight Chair starting Nov. 2017 from Harvard University where he was Professor at Harvard Medical School (HMS) and faculty at the Harvard-MIT’s Division of Health Sciences and Technology (HST), Brigham and Women’s Hospital (BWH) and as well as associate faculty at the Wyss Institute for Biologically Inspired Engineering. At Harvard University, he directed the Biomaterials Innovation Research Center (BIRC) a leading initiative in making engineered biomedical materials. He is a leader in applying bioengineering solutions to precision medicine. His large and interdisciplinary group is interested in developing ‘personalized’ solutions that utilize micro- and nanoscale technologies to enable a range of therapies for organ failure, cardiovascular disease and cancer. In enabling this vision, he works closely with clinicians (including interventional radiologists, cardiologists and surgeons). For example, he has developed numerous techniques in controlling the behavior of patient-derived cells to engineer artificial tissues and cell-based therapies. He is also developing ‘organ-on-a-chip’ systems that aim to mimic human physiology and pathology to enable patient-specific evaluation of drug candidates. In addition, his laboratory is a leader in utilizing biofabrication to form vascularized tissues with appropriate microarchitectures as well as regulating stem cell differentiation in microengineered environments. He has also pioneered various high-performance biomaterials that can respond to each patient’s needs. He has edited multiple books/journal special issues and is an author on >650 peer-reviewed journal articles, editorials and review papers, >70 book chapters/edited books and >20 patents/patent applications. His work has been published in leading journals and routinely highlighted in international media. He has been cited >65,000 times and has an H-index of 132. Also, he has given over >250 invited seminars and keynote lectures. For the past five years he has been selected by Thomson Reuters as one of the World’s Most Influential Minds as a Highly Cited Researcher. Dr. Khademhosseini’s interdisciplinary research has been recognized by over 60 major national and international awards. He is the recipient of the Presidential Early Career Award for Scientists and Engineers (PECASE), the highest honor given by the US government for early career investigators. In 2007, he was named a TR35 recipient by the Technology Review Magazine as one of the world’s top young innovators. In 2011, he received the Pioneers of Miniaturization Prize from the Royal Society of Chemistry (RSC) for his contribution to microscale tissue engineering and microfluidics. In 2016, he received the Sr. Scientist Award of Tissue Engineering and Regenerative Medicine Society-Americas (TERMIS-AM) and in 2017 he received the Clemson Award of the Society for Biomaterials. He is a fellow of the American Institute of Medical and Biological Engineering (AIMBE), Biomedical Engineering Society (BMES), Royal Society of Chemistry (RSC), Biomaterials Science and Engineering (FBSE), Materials Research Society (MRS), NANOSMAT Society, and American Association for the Advancement of Science (AAAS). He is also the recipient of the Mustafa Prize ($500,000 prize) as well as a member of the International Academy of Medical and Biological Engineering, Royal Society of Canada and Canadian Academy of Engineering. Dr. Khademhosseini is highly interested in training students and postdoctoral fellows for which he received the MIT’s Outstanding Undergraduate mentor. Over 50 of his previous train
show More
Preview
Evolution over the last 10 years of activity
Aggregated career metrics
1057
Total documents
4.24
Normalized Impact
405
Highly Cited Papers (10%)
62.54
International Collab. (%)
Most cited publications
Main coauthors
Following you can review Ali's accomplishments in each of the dimensions.
The perfect present for a young Researcher!
Let's do it!
Dimensions One by One
Spanning 73 diverse indicators, the dimensions considered capture a comprehensive spectrum of academic
attributes.
Each dimension includes a set of indicators and has a especific weight on the One Index.
More information here...
Activity
0
/1000
Reflects an author's research output.
Impact
0
/1000
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.
Excellence
0
/1000
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.
Leadership
0
/1000
Reflects an author's efforts and commitment in leading research initiatives.
Cooperation
0
/1000
Reflects a researcher's ability to navigate and thrive in varied academic and research environments, highlighting adaptability, resourcefulness, and the capacity to build and maintain collaborative relationships across the spectrum of their career.
Openness
0
/1000
Reflects an author's commitment to making their research freely accessible and open to the public.
Community Support
0
/1000
Reflects an author's contributions to the academic community beyond their own research.
Community Recognition
0
/1000
Reflects the academic community's acknowledgment and appreciation of an author's contributions.
Transference
0
/1000
Reflects an author's commitment to making their research a practical application and real-world impact of an author's research.
Fundraising
0
/1000
Reflects an author's ability in securing project funding from major global entities, showcasing your ability to drive research initiatives forward.
